<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Barletta JA</submitter><funding>NCI NIH HHS</funding><pagination>1706-1715</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9669222</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>46(12)</volume><pubmed_abstract>NUT carcinoma (NC) is a rare subtype of squamous cell carcinoma defined by NUTM1 rearrangements encoding NUT fusion oncoproteins (the most frequent fusion partner being BRD4 ) that carries a very poor prognosis, with most patients dying in under 1 year. Only rare primary thyroid NCs have been reported. Here, we evaluated a series of 14 cases. The median patient age at diagnosis was 38 years (range: 17 to 72 y). Eight of 13 cases with slides available for review (62%) showed a morphology typical of NC, whereas 5 (38%) had a non-NC-like morphology, some of which had areas of cribriform or fused follicular architecture resembling a follicular cell-derived thyroid carcinoma. For cases with immunohistochemistry results, 85% (11/13) were positive for NUT on biopsy or resection, though staining w</pubmed_abstract><journal>The American journal of surgical pathology</journal><pubmed_title>NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.</pubmed_title><pmcid>PMC9669222</pmcid><funding_grant_id>R01 CA124633</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><pubmed_authors>Bocklage T</pubmed_authors><pubmed_authors>Weissferdt A</pubmed_authors><pubmed_authors>Ghossein RA</pubmed_authors><pubmed_authors>Ng TL</pubmed_authors><pubmed_authors>Bell D</pubmed_authors><pubmed_authors>Chau NG</pubmed_authors><pubmed_authors>Limaye S</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>French CA</pubmed_authors><pubmed_authors>Lopez CA</pubmed_authors><pubmed_authors>Hertzler HJ</pubmed_authors><pubmed_authors>Boisselier P</pubmed_authors><pubmed_authors>Gilday SD</pubmed_authors><pubmed_authors>Xu B</pubmed_authors><pubmed_authors>Barletta JA</pubmed_authors><pubmed_authors>Cipriani NA</pubmed_authors><pubmed_authors>Afkhami M</pubmed_authors><pubmed_authors>Costes-Martineau V</pubmed_authors><pubmed_authors>Kramer AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.</name><description>NUT carcinoma (NC) is a rare subtype of squamous cell carcinoma defined by NUTM1 rearrangements encoding NUT fusion oncoproteins (the most frequent fusion partner being BRD4 ) that carries a very poor prognosis, with most patients dying in under 1 year. Only rare primary thyroid NCs have been reported. Here, we evaluated a series of 14 cases. The median patient age at diagnosis was 38 years (range: 17 to 72 y). Eight of 13 cases with slides available for review (62%) showed a morphology typical of NC, whereas 5 (38%) had a non-NC-like morphology, some of which had areas of cribriform or fused follicular architecture resembling a follicular cell-derived thyroid carcinoma. For cases with immunohistochemistry results, 85% (11/13) were positive for NUT on biopsy or resection, though staining w</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T09:50:15.936Z</modification><creation>2025-02-19T01:17:36.195Z</creation></dates><accession>S-EPMC9669222</accession><cross_references><pubmed>36040068</pubmed><doi>10.1097/pas.0000000000001967</doi><doi>10.1097/PAS.0000000000001967</doi></cross_references></HashMap>